vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Zeta Global Holdings Corp. (ZETA). Click either name above to swap in a different company.
Zeta Global Holdings Corp. is the larger business by last-quarter revenue ($394.6M vs $236.8M, roughly 1.7× CROSS COUNTRY HEALTHCARE INC). Zeta Global Holdings Corp. runs the higher net margin — 1.7% vs -35.0%, a 36.7% gap on every dollar of revenue. On growth, Zeta Global Holdings Corp. posted the faster year-over-year revenue change (25.4% vs -23.6%). Zeta Global Holdings Corp. produced more free cash flow last quarter ($60.9M vs $16.1M). Over the past eight quarters, Zeta Global Holdings Corp.'s revenue compounded faster (42.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Zeta Global Holdings Corp. is an American marketing technology company which was founded in 2007. Zeta offers companies a suite of multichannel marketing tools focused on creating, maintaining, and monetizing customer relationships. The company went public on the New York Stock Exchange on June 10, 2021, at a US$1.7 billion valuation.
CCRN vs ZETA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $394.6M |
| Net Profit | $-82.9M | $6.5M |
| Gross Margin | — | 59.5% |
| Operating Margin | -30.2% | 4.5% |
| Net Margin | -35.0% | 1.7% |
| Revenue YoY | -23.6% | 25.4% |
| Net Profit YoY | -2109.7% | -57.1% |
| EPS (diluted) | $-2.56 | $0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $394.6M | ||
| Q3 25 | $250.1M | $337.2M | ||
| Q2 25 | $274.1M | $308.4M | ||
| Q1 25 | $293.4M | $264.4M | ||
| Q4 24 | $309.9M | $314.7M | ||
| Q3 24 | $315.1M | $268.3M | ||
| Q2 24 | $339.8M | $227.8M | ||
| Q1 24 | $379.2M | $194.9M |
| Q4 25 | $-82.9M | $6.5M | ||
| Q3 25 | $-4.8M | $-3.6M | ||
| Q2 25 | $-6.7M | $-12.8M | ||
| Q1 25 | $-490.0K | $-21.6M | ||
| Q4 24 | $-3.8M | $15.2M | ||
| Q3 24 | $2.6M | $-17.4M | ||
| Q2 24 | $-16.1M | $-28.1M | ||
| Q1 24 | $2.7M | $-39.6M |
| Q4 25 | — | 59.5% | ||
| Q3 25 | 20.4% | 60.5% | ||
| Q2 25 | 20.4% | 62.1% | ||
| Q1 25 | 20.0% | 60.9% | ||
| Q4 24 | — | 60.0% | ||
| Q3 24 | 20.4% | 60.6% | ||
| Q2 24 | 20.8% | 60.0% | ||
| Q1 24 | 20.4% | 60.6% |
| Q4 25 | -30.2% | 4.5% | ||
| Q3 25 | -2.4% | 2.6% | ||
| Q2 25 | -2.1% | -1.7% | ||
| Q1 25 | -0.3% | -6.1% | ||
| Q4 24 | -1.1% | 2.2% | ||
| Q3 24 | 0.9% | -4.6% | ||
| Q2 24 | -5.7% | -11.7% | ||
| Q1 24 | 0.8% | -18.4% |
| Q4 25 | -35.0% | 1.7% | ||
| Q3 25 | -1.9% | -1.1% | ||
| Q2 25 | -2.4% | -4.2% | ||
| Q1 25 | -0.2% | -8.2% | ||
| Q4 24 | -1.2% | 4.8% | ||
| Q3 24 | 0.8% | -6.5% | ||
| Q2 24 | -4.7% | -12.3% | ||
| Q1 24 | 0.7% | -20.3% |
| Q4 25 | $-2.56 | $0.04 | ||
| Q3 25 | $-0.15 | $-0.02 | ||
| Q2 25 | $-0.20 | $-0.06 | ||
| Q1 25 | $-0.02 | $-0.10 | ||
| Q4 24 | $-0.13 | $0.10 | ||
| Q3 24 | $0.08 | $-0.09 | ||
| Q2 24 | $-0.47 | $-0.16 | ||
| Q1 24 | $0.08 | $-0.23 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $319.8M |
| Total DebtLower is stronger | — | $197.1M |
| Stockholders' EquityBook value | $322.8M | $804.6M |
| Total Assets | $449.0M | $1.5B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | $319.8M | ||
| Q3 25 | $99.1M | $385.2M | ||
| Q2 25 | $81.2M | $365.3M | ||
| Q1 25 | $80.7M | $364.4M | ||
| Q4 24 | $81.6M | $366.2M | ||
| Q3 24 | $64.0M | $418.5M | ||
| Q2 24 | $69.6M | $154.7M | ||
| Q1 24 | $5.2M | $141.6M |
| Q4 25 | — | $197.1M | ||
| Q3 25 | — | $196.9M | ||
| Q2 25 | — | $196.7M | ||
| Q1 25 | — | $196.5M | ||
| Q4 24 | — | $196.3M | ||
| Q3 24 | — | $196.1M | ||
| Q2 24 | — | $184.4M | ||
| Q1 24 | — | $184.2M |
| Q4 25 | $322.8M | $804.6M | ||
| Q3 25 | $408.1M | $689.2M | ||
| Q2 25 | $412.2M | $673.3M | ||
| Q1 25 | $418.2M | $676.6M | ||
| Q4 24 | $419.0M | $676.8M | ||
| Q3 24 | $424.7M | $474.9M | ||
| Q2 24 | $433.3M | $217.0M | ||
| Q1 24 | $462.4M | $191.6M |
| Q4 25 | $449.0M | $1.5B | ||
| Q3 25 | $538.2M | $1.2B | ||
| Q2 25 | $553.8M | $1.1B | ||
| Q1 25 | $576.2M | $1.1B | ||
| Q4 24 | $589.3M | $1.1B | ||
| Q3 24 | $597.4M | $869.1M | ||
| Q2 24 | $602.9M | $583.9M | ||
| Q1 24 | $648.4M | $550.3M |
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.85× | ||
| Q1 24 | — | 0.96× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $64.1M |
| Free Cash FlowOCF − Capex | $16.1M | $60.9M |
| FCF MarginFCF / Revenue | 6.8% | 15.4% |
| Capex IntensityCapex / Revenue | 0.9% | 0.8% |
| Cash ConversionOCF / Net Profit | — | 9.81× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $185.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $64.1M | ||
| Q3 25 | $20.1M | $57.9M | ||
| Q2 25 | $4.2M | $42.0M | ||
| Q1 25 | $5.7M | $34.8M | ||
| Q4 24 | $24.2M | $43.7M | ||
| Q3 24 | $7.5M | $34.4M | ||
| Q2 24 | $82.4M | $31.1M | ||
| Q1 24 | $6.0M | $24.7M |
| Q4 25 | $16.1M | $60.9M | ||
| Q3 25 | $17.9M | $52.4M | ||
| Q2 25 | $2.3M | $39.7M | ||
| Q1 25 | $3.8M | $32.1M | ||
| Q4 24 | $21.7M | $35.4M | ||
| Q3 24 | $6.3M | $29.5M | ||
| Q2 24 | $79.6M | $24.4M | ||
| Q1 24 | $3.8M | $18.9M |
| Q4 25 | 6.8% | 15.4% | ||
| Q3 25 | 7.2% | 15.6% | ||
| Q2 25 | 0.8% | 12.9% | ||
| Q1 25 | 1.3% | 12.1% | ||
| Q4 24 | 7.0% | 11.3% | ||
| Q3 24 | 2.0% | 11.0% | ||
| Q2 24 | 23.4% | 10.7% | ||
| Q1 24 | 1.0% | 9.7% |
| Q4 25 | 0.9% | 0.8% | ||
| Q3 25 | 0.9% | 1.6% | ||
| Q2 25 | 0.7% | 0.8% | ||
| Q1 25 | 0.6% | 1.0% | ||
| Q4 24 | 0.8% | 2.6% | ||
| Q3 24 | 0.4% | 1.8% | ||
| Q2 24 | 0.8% | 3.0% | ||
| Q1 24 | 0.6% | 3.0% |
| Q4 25 | — | 9.81× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 2.87× | ||
| Q3 24 | 2.92× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
ZETA
Segment breakdown not available.
